* Health Catalyst Inc HCAT.OQ reported quarterly adjusted
earnings of 3 cents per share for the quarter ended in
September, higher than the same quarter last year, when the
company reported EPS of -13 cents. The mean expectation of
fourteen analysts for the quarter was for a loss of 2 cents per
share. Wall Street expected results to range from -13 cents to 5
cents per share.
* Revenue rose 7.9% to $73.77 million from a year ago;
analysts
expected $72.66 million.
* Health Catalyst Inc's reported EPS for the quarter was a
loss
of 39 cents.
* The company reported a quarterly loss of $22.03 million.
* Health Catalyst Inc shares had fallen by 28.6% this
quarter and
lost 32.0% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 62% in
the last three months.
* In the last 30 days, there have been no negative revisions
of
earnings estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 8
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the software peer
group
is also "buy"
Wall Street's median 12-month price target for Health Catalyst
Inc is $14.00
This summary was machine generated from LSEG data November 2 at
10:27 p.m. UTC. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2023 -0.02 0.03 Beat
Jun. 30 2023 0.00 0.05 Beat
Mar. 31 2023 -0.04 0.05 Beat
Dec. 31 2022 -0.11 -0.05 Beat